Empowered Patient Podcast Developing Autologous Cell Therapy For Diabetic Foot Ulcer and Other Complex Wounds with Richard Hague PolarityTE
Richard Hague is the CEO and President of PolarityTE, creating a paste-like substance containing multicellular skin segments that can be spread on the patient's wound bed and engrafts into the wound. This stimulates healing from the inside out with wounds created by diabetic foot ulcer and venous leg ulcer.
Richard elaborates, "We're very excited about our SkinTE platform. It's a very unique and novel approach for treating wounds. The goal here is to use the patient's own cells so that there's no risk of rejection of any kind, no introduction of anything foreign to the body."
"The first thing that happens is a physician takes a very small, full thickness harvest from the patient's body, usually somewhere in the proximal calf area. So this is healthy tissue. It's a small harvest that's easily stitched up and closed. And that tissue is sent back to our facility in Salt Lake City. We have a proprietary process for processing that skin that allows us to utilize all aspects of that harvest. So we're using all layers of the cells and all the extracellular material that's in that full thickness skin."
@PolarityTE #PolarityTE #SkinTE #DiabeticFootUlcers #Diabetes #PressureUlcers